Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2026-01-20 @ 12:29 AM
Study NCT ID:
NCT05569057
Status:
UNKNOWN
Last Update Posted:
2022-10-07
First Post:
2022-09-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma
Sponsor:
Jiangsu Simcere Pharmaceutical Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SIM1811-03-TNFR2-102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None